Literature DB >> 1989392

Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines.

M Scarpa1, D Cournoyer, D M Muzny, K A Moore, J W Belmont, C T Caskey.   

Abstract

We have characterized the recombinant replication-competent retrovirus (RCV) arising from p delta N2-derived vectors in the packaging cell lines psi 2 (ecotropic) and PA317 (amphotropic). Detailed restriction patterns and sequence of the envelope region of these RCVs has indicated that they arose from recombination events between the virus plasmids used to create the packaging cell line and the vectors. There was no evidence of recombination involving endogenous murine retroviral sequences in the packaging cell line or in transduced hematopoietic cells. In addition, we have confirmed that the mutation of the start codon of the pXM5(N2) derivatives gag+ sequence drastically decreased the occurrence of RCV production. These results offer encouragement that the risk of RCV production can be adequately decreased in gene therapy applications of defective retrovirus vectors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1989392     DOI: 10.1016/0042-6822(91)90105-k

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Replication-competent lentivirus analysis of clinical grade vector products.

Authors:  Kenneth Cornetta; Jing Yao; Aparna Jasti; Sue Koop; Makhaila Douglas; David Hsu; Larry A Couture; Troy Hawkins; Lisa Duffy
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

Review 2.  Development of retroviral vectors as safe, targeted gene delivery systems.

Authors:  W H Günzburg; B Salmons
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

3.  Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.

Authors:  Kenneth Cornetta; Lisa Duffy; Cameron J Turtle; Michael Jensen; Stephen Forman; Gwendolyn Binder-Scholl; Terry Fry; Anne Chew; David G Maloney; Carl H June
Journal:  Mol Ther       Date:  2017-09-12       Impact factor: 11.454

4.  High-titer packaging cells producing recombinant retroviruses resistant to human serum.

Authors:  F L Cosset; Y Takeuchi; J L Battini; R A Weiss; M K Collins
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  Screening retroviral packaging cells for highly efficient virus production by using a combined selection procedure.

Authors:  M Wirth; R Grannemann; D Klehr; H Hauser
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

6.  Gene transfer into hematopoietic stem cells: long-term maintenance of in vitro activated progenitors without marrow ablation.

Authors:  D Bienzle; A C Abrams-Ogg; S A Kruth; J Ackland-Snow; R F Carter; J E Dick; R M Jacobs; S Kamel-Reid; I D Dubé
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

7.  A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral Vectors.

Authors:  Semih U Tareen; Christopher J Nicolai; David J Campbell; Patrick A Flynn; Megan M Slough; Chintan D Vin; Brenna Kelley-Clarke; Jared M Odegard; Scott H Robbins
Journal:  Biores Open Access       Date:  2013-12-01

8.  Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience.

Authors:  Kenneth Cornetta; Lisa Duffy; Steven A Feldman; Crystal L Mackall; Marco L Davila; Kevin J Curran; Richard P Junghans; Jean Yuh Tang; James N Kochenderfer; Roisin O'Cearbhaill; Gary Archer; Hans-Peter Kiem; Nirali N Shah; Cindy Delbrook; Rosie Kaplan; Renier J Brentjens; Isabelle Rivière; Michel Sadelain; Steven A Rosenberg
Journal:  Mol Ther Methods Clin Dev       Date:  2018-08-17       Impact factor: 6.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.